Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.91 -0.12 (-2.39%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vanda Pharmaceuticals (VNDA) Operating Margin (2010 - 2026)

Updated

Vanda Pharmaceuticals (VNDA) reported Operating Margin of -126.28% for Q2 2026, down 53.07 percentage points from -73.21% a year earlier and down 29.17 percentage points from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Operating Margin (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Vanda Pharmaceuticals' Operating Margin came in at -86.07%, down 36.52 percentage points year-over-year; for FY2025, it came in at -69.95%, down 49.50 percentage points from FY2024.

  • Operating Margin has declined for four consecutive years, with a five-year change of -80.93 percentage points (FY2020 to FY2025).
  • By year, Operating Margin came in at -20.46% in FY2024 (-13.21 pp), -7.24% in FY2023 (-9.73 pp), 2.49% in FY2022 (-13.21 pp) and 15.69% in FY2021 (+4.72 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Operating Margin since Q2 2014.
  • Year over year, Operating Margin has now declined in each of the last 13 quarters, with an average year-over-year change of -34.86 percentage points over the last eight quarters.
  • The high point for year-over-year Operating Margin in five years was Q1 2023 (a gain of 15.95 percentage points); the low point was Q1 2025 (a drop of 62.53 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -97.11% (Q1 2026), -70.53% (Q4 2025) and -55.61% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Vanda Pharmaceuticals 304.09 Mn -625.85 Mn 46.97 Mn -126.28%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -126.28%
Mar 31, 2026 -97.11%
Dec 31, 2025 -70.53%
Sep 30, 2025 -55.61%
Jun 30, 2025 -73.21%
Mar 31, 2025 -81.99%
Dec 31, 2024 -19.33%
Sep 30, 2024 -23.08%
Jun 30, 2024 -20.10%
Mar 31, 2024 -19.46%
Dec 31, 2023 -15.67%
Sep 30, 2023 -15.45%
Jun 30, 2023 -6.23%
Mar 31, 2023 3.21%
Dec 31, 2022 10.28%
Sep 30, 2022 5.98%
Jun 30, 2022 5.38%
Mar 31, 2022 -12.74%
Dec 31, 2021 12.70%
Sep 30, 2021 15.43%
API Access

Vanda Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=VNDA&period=max&api_key=YOUR_API_KEY